Your teeth may begin to space out. Your brow and lower jaw may start to jut out from your face. To tell for sure if you have acromegaly, your doctor will run a few tests, including: A blood test ...

Gigantism and acromegaly are growth disorders that result from excess amounts of growth hormone in the body. The conditions are similar but have several differences. Growth hormone is one of the ...

Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true ...

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events ...

Crinetics is seeking to change the way acromegaly is treated. Ahead of its hopes for a 2025 U.S. drug launch, the biotech is looking to spread awareness about how to treat the condition.

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

An AI model correctly identified 22 of 31 adults as having acromegaly strictly based on voice recordings. The model had a higher area under the receiver operating curve than a group of ...

An investigational treatment for acromegaly -- also known as gigantism -- was safe and boosted biochemical control, according to final topline findings of the phase III ACROINNOVA 2 study.

Fifty-four percent of adults with acromegaly receiving pasireotide reached an IGF-I level less than or equal to the upper limit of normal. Pasireotide was associated with reductions in tumor ...